Entity
Description
  • Value proposition

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

    Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivation

  • Original language

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

  • TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All

    TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.

  • https://treefrog.fr/
Catalyst interactions
Catalyst TypeTweets Articles
Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Other

15 Feb 2023


Merck Group
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Other

25 Oct 2022


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

25 Oct 2022


France Travail
France Travail
Human ressources, Government Administration
France Travail
Human ressources, Government Administration
Other

1 Jun 2021

4 Oct 2024



KPMG
KPMG
Consulting, audit, Accounting
KPMG
Consulting, audit, Accounting
Other

7 Jul 2022


Bayer
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Other

25 Jul 2022


Matmut
Matmut
Insurance
Matmut
Insurance
Other

2 Oct 2019


XAnge
XAnge
Startup accelerator & VC, Venture Capital and Private Equity Principals
XAnge
Startup accelerator & VC, Venture Capital and Private Equity Principals
Capitalistic
Not partnership
Not event

13 Sep 2021

27 May 2024



Leem
Leem
Startup accelerator & VC, Pharmaceutical Manufacturing
Leem
Startup accelerator & VC, Pharmaceutical Manufacturing
Other

17 Nov 2020

4 Oct 2024



France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

7 Oct 2020

12 Apr 2025



Social network dynamics
Similar entities
BETA
Loading...
Loading...